ARWR — Arrowhead Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $8.26bn
- $7.92bn
- $829.45m
US STOCKS ON THE MOVE-Netflix, Coinbase Global, Accenture
US STOCKS ON THE MOVE-Bending Spoons, Skydance, Albertsons
US STOCKS ON THE MOVE-Albertsons, GlobalFoundries, American Electric Power, Fastenal
Brief: Arrowhead Pharmaceuticals Announces ARO-MAPT Interim Phase 1/2a Clinical Data Demonstrating Deep and Durable Tau Reductions in Healthy Volunteers
Arrowhead climbs on early Alzheimer's drug trial data
Brief: Arrowhead Pharmaceuticals Granted Entry In The FDA Star Pilot Program For Plozasiran In Severe Hypertriglyceridemia
Brief: Arrowhead Pharmaceuticals Presents Phase 3 Shasta-3 And Shasta-4 Data Demonstrating Plozasiran Reduced Acute Pancreatitis Events In Patients With Severe Hypertriglyceridemia
U.S. RESEARCH ROUNDUP-Ametek, Ball Corp, McDonald's
Arrowhead Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Arrowhead Pharmaceuticals Q3 revenue jumps on REDEMPLO growth
Brief: Arrowhead Pharmaceuticals Q3 EPS USD -1.36
Brief: Arrowhead Pharmaceuticals Completes Enrollment In Global Phase 3 Yosemite Study Of Zodasiran For The Treatment Of Homozygous Familial Hypercholesterolemia
U.S. RESEARCH ROUNDUP-Alphabet, IBM, Tesla
U.S. STOCKS ON THE MOVE-Wabtec, Chubb, CME Group
U.S. STOCKS ON THE MOVE-Wabtec, Johnson & Johnson, CME Group
U.S. STOCKS ON THE MOVE-GE Vernova, Arrowhead Pharma
Arrowhead rises after blood-fat drug meets late-stage trial goals
Arrowhead rises after blood-fat drug meets late-stage trial goals
U.S. RESEARCH ROUNDUP-Applied Materials, McDonald's, McKesson